کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10047788 | 1598410 | 2005 | 5 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
بیماریهای کلیوی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Background: Voriconazole is a new triazole antifungal drug. Its pharmacokinetics and transfer to peritoneal dialysate in peritoneal dialysis (PD) patients have not been studied. Methods: Five patients with end-stage renal disease requiring support by PD were administered a single dose of 200 mg of voriconazole orally. Plasma and peritoneal dialysate were collected for measurement of voriconazole concentrations at times 1, 2, 4, and 24 hours. Results: Voriconazole was absorbed and achieved maximum concentration (Cmax) in plasma at mean time 2.4 ± 0.7 (SE) hours. Time to Cmax in dialysate was 2.8 ± 0.5 hours. Mean Cmax for plasma was 0.55 ± 0.20 μg/mL, and for dialysate, approximately half that of plasma (0.25 ± 0.09 μg/mL). The dialysate to plasma ratio of voriconazole was 0.66 ± 0.11. Less than 1% of the administered voriconazole dose (1.3 ± 0.2 mg) was recovered in dialysate 24 hours after dosing. Conclusion: Voriconazole penetrates well into peritoneal fluid. There is minimal peritoneal clearance of voriconazole; therefore, no dosage adjustment is needed for patients on PD therapy.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: American Journal of Kidney Diseases - Volume 45, Issue 1, January 2005, Pages 162-166
Journal: American Journal of Kidney Diseases - Volume 45, Issue 1, January 2005, Pages 162-166
نویسندگان
Luon W. MD, Yeong-Hau H. MD, PhD,